North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Product Description
In-house Standards
AI Product Description
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Axitinib (CAS <strong>319460-85-0</strong>) is a potent, selective small-molecule inhibitor of vascular endothelial growth factor receptors (VEGFRs). Manufactured via advanced organic synthesis, its molecular formula is <strong>C22H21FN4O2</strong>.</p>
<h3>Application</h3>
<ul>
<li><strong>Oncology:</strong> Second-line treatment for advanced renal cell carcinoma.</li>
<li><strong>Pharmaceutical R&D:</strong> Clinical trial agent for angiogenesis inhibition studies.</li>
<li><strong>Bulk Supply:</strong> Active Pharmaceutical Ingredient (API) for generic formulation production.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly store below 25°C in dry conditions. Handle with PPE due to potential toxicity; avoid inhalation or skin contact during manufacturing and compounding processes.</p>